US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Spdr S&P Biotech Etf

133.80

+3.973.06%

Volume:5.47M

Turnover:728.84M

Market Cap:8.16B

PE:7.34

High:134.47

Open:130.65

Low:130.44

Close:129.83

52wk High:139.19

52wk Low:80.90

Shares:61.00M

Float Shares:61.00M

Volume Ratio:0.78

T/O Rate:8.97%

Dividend:0.44

Dividend Rate:0.33%

EPS(TTM):18.23

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Sector Update: Healthcare

MT Newswires Live

Health Care Roundup: Market Talk

Analysts Offer Insights on Healthcare Companies: Fennec Pharmaceuticals (FENC) and Sutro Biopharma (STRO)

Analysts Offer Insights on Healthcare Companies: Coya Therapeutics, Inc. (COYA), Beta Bionics, Inc. (BBNX) and Arvinas Holding Company (ARVN)

Henlius Wins Key EMA Backing for Serplulimab Lung Cancer Use

Top Eminent Healthcare Faces Adverse Court Ruling in Banclogix Dispute

Analysts Offer Insights on Healthcare Companies: Whitehawk Therapeutics (WHWK) and Eledon Pharmaceuticals (ELDN)

Oncolytics Biotech to present data at ASCO 2026 on pelareorep

Oncolytics Highlights Pelareorep Immune Activation Data at ASCO

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Cardiff Oncology (CRDF), ACADIA Pharmaceuticals (ACAD) and Immunic (IMUX)

Oncolytics Biotech® to Present Data at ASCO 2026 Reinforcing Pelareorep’s Potential Across Gastrointestinal Tumors

Kelun Biotech to Present Study Results of Cancer Drugs at American Oncology Meeting

MT Newswires Live

New Century Healthcare Shareholders Unanimously Back AGM Resolutions

Kelun-Biotech says sac-TMT study selected for oral presentation at ASCO

Krystal Biotech (KRYS) Gets a Buy from Bank of America Securities

Krystal Biotech Price Target Maintained With a $310.00/Share by HC Wainwright & Co.

Analysts Offer Insights on Healthcare Companies: Arrowhead Pharmaceuticals (ARWR), Black Diamond Therapeutics (BDTX) and Iovance Biotherapeutics (IOVA)

Analysts Offer Insights on Healthcare Companies: IN8bio (INAB), Syndax Pharmaceuticals (SNDX) and Olema Pharmaceuticals (OLMA)

OUE Healthcare Publishes AGM Minutes and Outlines Strategy Shift Toward Specialised, Integrative Care

Bamboos Health Care Announces Resignation of Executive Director

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/XBI/news?page=22"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"XBI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBI\",,,,,undefined,":{"symbol":"XBI","market":"US","secType":"STK","nameCN":"Spdr S&P Biotech Etf","latestPrice":133.8,"timestamp":1780598386466,"preClose":129.83,"halted":0,"volume":5468981,"delay":0,"changeRate":0.030578448740660853,"floatShares":61000000,"shares":61000000,"eps":18.23,"marketStatus":"Trading","change":3.97,"latestTime":"06-04 14:39:47 EDT","open":130.65,"high":134.47,"low":130.44,"amount":728835073.75567,"amplitude":0.031041,"askPrice":133.82,"askSize":310,"bidPrice":133.78,"bidSize":4,"shortable":3,"etf":1,"ttmEps":18.23,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1780603200000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":129.83,"sharesOutstanding":63325000,"nav":127.756538,"aum":7920905343.3,"dividendRate":0.003299,"bidAskSpread":0.000251,"preHourTrading":{"tag":"盘前","latestPrice":130.55,"preClose":129.83,"latestTime":"09:29 EDT","volume":5570,"amount":726386.2065,"timestamp":1780579799999,"change":0.72,"changeRate":0.005546,"amplitude":0.012324},"postHourTrading":{"tag":"盘后","latestPrice":129.8,"preClose":129.83,"latestTime":"19:56 EDT","volume":144775,"amount":18792421.2052,"timestamp":1780530981646,"change":-0.03,"changeRate":-0.000231,"amplitude":0.003158},"volumeRatio":0.784706,"optionData":{"bulkOrders":[{"symbol":"XBI","call":false,"expireDate":1781755200000,"strike":"125.0","timestamp":1780581960495,"price":0.72,"volume":1173,"amount":84456,"type":"-"}]},"impliedVol":0.3155,"impliedVolPercentile":0.7331},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBI\",,,,,undefined,":{"symbol":"XBI","floatShares":61000000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.784706,"shares":61000000,"dividePrice":0.4414,"high":134.47,"amplitude":0.031041,"preClose":129.83,"low":130.44,"week52Low":80.9,"pbRate":"--","week52High":139.19,"institutionHeld":0.8511,"latestPrice":133.8,"committee":-0.976048,"eps":18.23,"divideRate":0.003299,"volume":5468981,"delay":0,"ttmEps":18.23,"open":130.65,"prevYearClose":121.93,"prevWeekClose":136.69,"prevMonthClose":136.69,"prevQuarterClose":127.73,"fiveDayClose":135.99,"twentyDayClose":137.68,"sixtyDayClose":127.43},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/XBI\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"XBI","amount":0.406564,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-24"},{"date":"2025-09-22","symbol":"XBI","amount":0.02665,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-24","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-24"},{"date":"2025-06-23","symbol":"XBI","amount":0.007295,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-25","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-25"},{"date":"2025-03-24","symbol":"XBI","amount":0.00525,"announcedDate":"2025-03-21","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-24","defaultRemindTime":1742823000000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-26","payableDate":"2025-03-24","currency":"USD","dateTimestamp":1742788800000,"payDate":"2025-03-26"},{"date":"2024-12-23","symbol":"XBI","amount":0.002687,"announcedDate":"2024-12-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-23","defaultRemindTime":1734964200000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-26","payableDate":"2024-12-23","currency":"USD","dateTimestamp":1734930000000,"payDate":"2024-12-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"XBI\",market:\"US\",,,undefined,":[{"executeDate":"2016-06-17","recordDate":"2016-06-21","paymentDate":"2016-06-27","value":0.045491,"currency":"USD"},{"executeDate":"2016-09-16","recordDate":"2016-09-20","paymentDate":"2016-09-26","value":0.031139,"currency":"USD"},{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-27","value":0.01831,"currency":"USD"},{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-27","value":0.019702,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-26","value":0.110135,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"XBI\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"XBI\",pageSize:20,pageCount:22,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2637660346","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2637660346","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637660346?lang=en_us&edition=fundamental","pubTime":"2026-05-23 01:06","pubTimestamp":1779469590,"startTime":"0","endTime":"0","summary":"Healthcare stocks rose Friday afternoon, with the NYSE Healthcare Index advancing 1% and the State Street Health Care Select Sector SPDR ETF  adding 1.1%.The iShares Biotechnology ETF  increased 0.1%.In corporate news, Merck  said Friday the European Medicines Agency's Committee for Medicinal Products for Human Use has recommended the approval of Keytruda, in combination with Padcev, to treat a type of bladder cancer. Merck shares jumped 5.2%.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1061106388.HKD","LU1934455277.USD","LU2357627491.SGD","LU0980610538.SGD","IE00B2B36J28.USD","SG9999001176.USD","LU2491050154.USD","LU1162221912.USD","LU2125909247.SGD","LABU","LU2023250504.SGD","SG9999014542.SGD","LU0320765646.SGD","LU0965508806.USD","LU2125909593.SGD","XBI","LU0648001328.SGD","BK4550","BK4588","XLV","BK4007","LU1037948897.HKD","LU2112291526.USD","LU0265550946.USD","LU1989772840.SGD","SG9999015358.SGD","LU0868494617.USD","LU1035773651.USD","SG9999002224.SGD","LU2106854487.HKD","LU0070302665.USD","LU0477156953.USD","LU0320765489.SGD","LU2361044949.HKD","SG9999013999.USD","LU0265550359.USD","LU2433249047.HKD","LU1585245621.USD","LU0432979614.USD","LU1116320737.USD","LU1989772923.USD","SGXZ57979304.SGD","LU2491049909.HKD","LU0985320562.USD","LU1201861249.SGD","LU1974910355.USD","SG9999001440.SGD","LU1430594728.SGD","LU1989771016.USD","LU1066053197.SGD","LU0122379950.USD","LU2324357040.USD","LU2125154935.USD","SG9999015341.SGD","LU1066051811.HKD","LU1934455194.USD","LU1093756168.USD","BK4534","BK4585","LU2089984988.USD","LU2491050071.SGD","LU1571399168.USD","LU0238689110.USD","LU2361044865.SGD","BK4533","LU0208291251.USD","LU0289739699.SGD","LU1057294990.SGD","LU1923622614.USD","IE00B1BXHZ80.USD","LU2361045086.USD","LU2125154778.USD","LU1983299246.USD","LU0098860793.USD","LU2360032135.SGD","IE00BJJMRZ35.SGD","IE0002141913.USD","LU0965509010.AUD","LU1917777945.USD","LU1699723380.USD","SG9999001176.SGD","IE00BLSP4452.SGD","LU0942090050.USD","LU0211331839.USD","LU1929549753.HKD","LU1116320901.HKD","LU1023059063.AUD","MRK","IE00BBT3K403.USD","LU1037948541.HKD","IE00BJT1NW94.SGD","LU0130517989.USD","LU0203345920.USD","BK4559","LU0106261372.USD","LU1066051225.USD","LU2023250843.SGD","IE0009355771.USD","IE00BSNM7G36.USD","SG9999014575.USD","IBB","LU1941712348.USD","LU0266013472.USD","LU0058720904.USD","IE00BLSP4239.USD","LU1934455863.HKD","LU0965509283.SGD","LU1093756325.SGD","IE000M9KFDE8.USD","SG9999014559.SGD","LU0859254822.USD","LU1069347547.HKD","LU1941712264.USD","LU0006306889.USD","LU0130102774.USD","LU0965509101.SGD","SG9999014567.USD","IE00BN8TJ469.HKD","LU2461242641.AUD","LU2468319806.SGD","LU0868494708.USD","LU1066051498.USD","LU1291159041.SGD","BK4581","LU0861579265.USD","IE00B4R5TH58.HKD","LU0203347892.USD","BK4516","IE00BFTCPJ56.SGD","LU0234572021.USD","SG9999002232.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637451723","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2637451723","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637451723?lang=en_us&edition=fundamental","pubTime":"2026-05-23 00:20","pubTimestamp":1779466800,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.0535 ET - CVC Capital Partners has teamed up with Groupe Bruxelles Lambert to launch a 10.73 billion euro bid for Italian drugmaker Recordati, in a move that might prelude future deals, RBC Capital Markets' Natalia Webster and Charles Weston say in a research note. The bidders' strategic rationale centers on Recordati's requirement for increased research-and-development spending as well as future mergers and acquisitions, the analysts say. Amsterdam-listed buyout group CVC is Recordati's controlling shareholder and the bid is aimed at taking Recordati private, the analysts say. Shares in Recordati fall 0.3%, while CVC and GBL both trade 1% higher. ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","XLV","BK4588","BK4585","XBI","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637343416","title":"Analysts Offer Insights on Healthcare Companies: Fennec Pharmaceuticals (FENC) and Sutro Biopharma (STRO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2637343416","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637343416?lang=en_us&edition=fundamental","pubTime":"2026-05-22 23:40","pubTimestamp":1779464420,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Fennec Pharmaceuticals (FENC) and Sutro Biopharma (STRO). Fennec ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-fennec-pharmaceuticals-fenc-and-sutro-biopharma-stro-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-fennec-pharmaceuticals-fenc-and-sutro-biopharma-stro-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","BK4585","LU0128526141.USD","XBI","STRO","BK4581","BK4139","XLV","BK4588","FENC","BK4137","LU0029874061.USD","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637310178","title":"Analysts Offer Insights on Healthcare Companies: Coya Therapeutics, Inc. (COYA), Beta Bionics, Inc. (BBNX) and Arvinas Holding Company (ARVN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2637310178","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637310178?lang=en_us&edition=fundamental","pubTime":"2026-05-22 22:20","pubTimestamp":1779459618,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Coya Therapeutics, Inc. (COYA), Beta Bionics, Inc. (...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-coya-therapeutics-inc-coya-beta-bionics-inc-bbnx-and-arvinas-holding-company-arvn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-coya-therapeutics-inc-coya-beta-bionics-inc-bbnx-and-arvinas-holding-company-arvn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","LU0128526141.USD","BK4588","BK4139","HCSG","XLV","ARVN","LABU","BK4082","LU0029874061.USD","BBNX","COYA","BK4581","BK4007","BK4585","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637310480","title":"Henlius Wins Key EMA Backing for Serplulimab Lung Cancer Use","url":"https://stock-news.laohu8.com/highlight/detail?id=2637310480","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637310480?lang=en_us&edition=fundamental","pubTime":"2026-05-22 22:10","pubTimestamp":1779459017,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Shanghai Henlius Biotech, Inc. Class H ( ($HK:2696) ). Shanghai Henlius Biotech said its anti-PD-1 monoclonal a...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/henlius-wins-key-ema-backing-for-serplulimab-lung-cancer-use?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/henlius-wins-key-ema-backing-for-serplulimab-lung-cancer-use?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4081","BK4581","BK4588","EMA","BK4585","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637310496","title":"Top Eminent Healthcare Faces Adverse Court Ruling in Banclogix Dispute","url":"https://stock-news.laohu8.com/highlight/detail?id=2637310496","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637310496?lang=en_us&edition=fundamental","pubTime":"2026-05-22 22:09","pubTimestamp":1779458969,"startTime":"0","endTime":"0","summary":"CLSA Premium Ltd. ( ($HK:6877) ) has provided an update. Top Eminent Healthcare Group Limited, a Hong Kong-listed healthcare group incorporated in ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/top-eminent-healthcare-faces-adverse-court-ruling-in-banclogix-dispute?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/top-eminent-healthcare-faces-adverse-court-ruling-in-banclogix-dispute?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","LU0029874061.USD","BK4581","XBI","BK4585","HCSG","IXJ","LABU","XLV","BK4588","VHT","BK4550","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637022317","title":"Analysts Offer Insights on Healthcare Companies: Whitehawk Therapeutics (WHWK) and Eledon Pharmaceuticals (ELDN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2637022317","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637022317?lang=en_us&edition=fundamental","pubTime":"2026-05-22 22:00","pubTimestamp":1779458442,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Whitehawk Therapeutics (WHWK) and Eledon Pharmaceuti...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-whitehawk-therapeutics-whwk-and-eledon-pharmaceuticals-eldn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-whitehawk-therapeutics-whwk-and-eledon-pharmaceuticals-eldn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ELDN","WHWK","BK4585","LU0029874061.USD","LABU","BK4588","LU0128526141.USD","BK4581","XLV","HCSG","XBI","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637031704","title":"Oncolytics Biotech to present data at ASCO 2026 on pelareorep","url":"https://stock-news.laohu8.com/highlight/detail?id=2637031704","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637031704?lang=en_us&edition=fundamental","pubTime":"2026-05-22 21:45","pubTimestamp":1779457550,"startTime":"0","endTime":"0","summary":"Oncolytics (ONCY) Biotech announced translational data from the GOBLET and AWARE-1 trials will be presented at the 2026 American Society of Clinica...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/oncolytics-biotech-to-present-data-at-asco-2026-on-pelareorep-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/oncolytics-biotech-to-present-data-at-asco-2026-on-pelareorep-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","BK4139","BK4588","XBI","BK4585","ONCY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637031768","title":"Oncolytics Highlights Pelareorep Immune Activation Data at ASCO","url":"https://stock-news.laohu8.com/highlight/detail?id=2637031768","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637031768?lang=en_us&edition=fundamental","pubTime":"2026-05-22 21:33","pubTimestamp":1779456832,"startTime":"0","endTime":"0","summary":"Oncolytics Biotech ( ($ONCY) ) just unveiled an update. On May 22, 2026, Oncolytics Biotech announced that translational data from its GOBLET and A...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/oncolytics-highlights-pelareorep-immune-activation-data-at-asco?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/oncolytics-highlights-pelareorep-immune-activation-data-at-asco?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","BK4581","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637546317","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Cardiff Oncology (CRDF), ACADIA Pharmaceuticals (ACAD) and Immunic (IMUX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2637546317","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637546317?lang=en_us&edition=fundamental","pubTime":"2026-05-22 21:30","pubTimestamp":1779456624,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Cardiff Oncology (CRDF), ACADIA Pharmaceuticals (ACAD) and Immuni...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-cardiff-oncology-crdf-acadia-pharmaceuticals-acad-and-immunic-imux-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-cardiff-oncology-crdf-acadia-pharmaceuticals-acad-and-immunic-imux-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","BK4585","BK4137","BK4139","BK4581","LU0029874061.USD","XBI","HCSG","LABU","LU2065169927.USD","IMUX","LU2065171402.SGD","LU0128526141.USD","LU2065170008.USD","CRDF","BK4588","ACAD","LU2065171311.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637312876","title":"Oncolytics Biotech® to Present Data at ASCO 2026 Reinforcing Pelareorep’s Potential Across Gastrointestinal Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2637312876","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637312876?lang=en_us&edition=fundamental","pubTime":"2026-05-22 21:00","pubTimestamp":1779454800,"startTime":"0","endTime":"0","summary":"Translational data demonstrate induction of both innate and adaptive antiviral and anti-tumor specific immune responses capable of controlling tumor growthSAN DIEGO, May  22, 2026  (GLOBE NEWSWIRE) --","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/22/3300127/0/en/Oncolytics-Biotech-to-Present-Data-at-ASCO-2026-Reinforcing-Pelareorep-s-Potential-Across-Gastrointestinal-Tumors.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","XBI","BK4097","BK4581","TLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637143983","title":"Kelun Biotech to Present Study Results of Cancer Drugs at American Oncology Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2637143983","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637143983?lang=en_us&edition=fundamental","pubTime":"2026-05-22 20:41","pubTimestamp":1779453682,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech Biopharmaceutical  will present the results of its registrational studies on sacituzumab tirumotecan  and lunbotinib fumarate at the 2026 American Society of Clinical Oncology annual meeting, according to a filing by parent Sichuan Kelun Pharmaceutical  with the Shenzhen bourse.Its study on its sacituzumab tirumotecan drug versus pembrolizumab for advanced non-small cell lung cancer treatment showed a higher response rate for its sac-TMT against pembrolizumab, the filing said.The company will also present results from its study on lunbotinib, which showed an objective response rate of 87.1% on patients with RET-fusion positive non-small cell lung cancer in patients with prior chemotherapy.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["06990","BK4585","LU0196878994.USD","LU1064130708.USD","LU1934453819.USD","XBI","BK0060","BK1161","LU1064131003.USD","BK0239","BK4107","LU1979443071.USD","LU2148510915.USD","BK4588","BK4117","AFG","002422","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637314378","title":"New Century Healthcare Shareholders Unanimously Back AGM Resolutions","url":"https://stock-news.laohu8.com/highlight/detail?id=2637314378","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637314378?lang=en_us&edition=fundamental","pubTime":"2026-05-22 20:37","pubTimestamp":1779453471,"startTime":"0","endTime":"0","summary":"The latest update is out from New Century Healthcare Holding Co. Ltd. ( ($HK:1518) ). New Century Healthcare Holding Co. Ltd. reported that all res...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/new-century-healthcare-shareholders-unanimously-back-agm-resolutions?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/new-century-healthcare-shareholders-unanimously-back-agm-resolutions?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","BK4229","BK4588","CNBKA","HCSG","LU0128526141.USD","AGM","LU0029874061.USD","BK4195","BK4581","XBI","LABU","BK4585","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637140311","title":"Kelun-Biotech says sac-TMT study selected for oral presentation at ASCO","url":"https://stock-news.laohu8.com/highlight/detail?id=2637140311","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637140311?lang=en_us&edition=fundamental","pubTime":"2026-05-22 20:18","pubTimestamp":1779452303,"startTime":"0","endTime":"0","summary":"Two registrational studies of the trophoblast cell-surface antigen 2-directed antibody drug conjugate sacituzumab tirumotecan, or sac-TMT, and the ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/kelun-biotech-says-sac-tmt-study-selected-for-oral-presentation-at-asco-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/kelun-biotech-says-sac-tmt-study-selected-for-oral-presentation-at-asco-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","BK4585","XBI","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637162433","title":"Krystal Biotech (KRYS) Gets a Buy from Bank of America Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2637162433","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637162433?lang=en_us&edition=fundamental","pubTime":"2026-05-22 19:16","pubTimestamp":1779448599,"startTime":"0","endTime":"0","summary":"Bank of America Securities analyst Alec Stranahan maintained a Buy rating on Krystal Biotech today and set a price target of $364.00. According to ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/krystal-biotech-krys-gets-a-buy-from-bank-of-america-securities-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/krystal-biotech-krys-gets-a-buy-from-bank-of-america-securities-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0980610538.SGD","BK4581","XBI","IE00B19Z3B42.SGD","IE0001KFT4U8.USD","PGF","LU1267930227.SGD","LU0256863902.USD","LU0208291251.USD","LU0320765646.SGD","LU1201861249.SGD","LU1162221912.USD","BK4559","BK4582","LU0053666078.USD","LU1496350171.SGD","IE00BLSP4239.USD","LU1804176565.USD","LU2129689605.HKD","LU0106831901.USD","BK4553","LU1883839398.USD","LU0130102774.USD","LU0234570918.USD","LU0314106906.USD","LU1718418525.SGD","LU0052756011.USD","LU0203345920.USD","LU1363072403.SGD","BAC","LU0868494617.USD","LU1668664300.SGD","LU0310800965.SGD","LU1366192091.USD","LU1880398554.USD","LU0211331839.USD","LU1894683348.USD","IE00BKVL7J92.USD","LU0477156797.USD","LU0683600562.USD","LU0130517989.USD","LU0477156953.USD","LU1880398471.USD","LU1791807156.HKD","BK4504","LU2129689514.USD","LU1069347547.HKD","KRYS","LU0128525689.USD","LU0320765489.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637170316","title":"Krystal Biotech Price Target Maintained With a $310.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2637170316","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637170316?lang=en_us&edition=fundamental","pubTime":"2026-05-22 19:14","pubTimestamp":1779448440,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/KRYS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 22, 2026 07:14 ET (11:14 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637315629","title":"Analysts Offer Insights on Healthcare Companies: Arrowhead Pharmaceuticals (ARWR), Black Diamond Therapeutics (BDTX) and Iovance Biotherapeutics (IOVA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2637315629","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637315629?lang=en_us&edition=fundamental","pubTime":"2026-05-22 18:30","pubTimestamp":1779445858,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Arrowhead Pharmaceuticals (ARWR), Black Diamond Ther...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-arrowhead-pharmaceuticals-arwr-black-diamond-therapeutics-bdtx-and-iovance-biotherapeutics-iova-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-arrowhead-pharmaceuticals-arwr-black-diamond-therapeutics-bdtx-and-iovance-biotherapeutics-iova-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","BK4137","BK4581","XBI","BK4588","BDTX","BK4585","LU0029874061.USD","LU0128526141.USD","XLV","ARWR","LABU","IOVA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637313486","title":"Analysts Offer Insights on Healthcare Companies: IN8bio (INAB), Syndax Pharmaceuticals (SNDX) and Olema Pharmaceuticals (OLMA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2637313486","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637313486?lang=en_us&edition=fundamental","pubTime":"2026-05-22 18:21","pubTimestamp":1779445306,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on IN8bio (INAB), Syndax Pharmaceuticals (SNDX) and Ole...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-in8bio-inab-syndax-pharmaceuticals-sndx-and-olema-pharmaceuticals-olma-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-in8bio-inab-syndax-pharmaceuticals-sndx-and-olema-pharmaceuticals-olma-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4139","SNDX","HCSG","INAB","LABU","BK4137","BK4581","BK4505","LU0029874061.USD","XLV","BK4539","OLMA","BK4588","XBI","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637792318","title":"OUE Healthcare Publishes AGM Minutes and Outlines Strategy Shift Toward Specialised, Integrative Care","url":"https://stock-news.laohu8.com/highlight/detail?id=2637792318","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637792318?lang=en_us&edition=fundamental","pubTime":"2026-05-22 17:49","pubTimestamp":1779443362,"startTime":"0","endTime":"0","summary":"OUE Lippo Healthcare Limited ( ($SG:5WA) ) has shared an announcement. OUE Healthcare Limited has published the minutes of its 24 April 2026 annual...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/oue-healthcare-publishes-agm-minutes-and-outlines-strategy-shift-toward-specialised-integrative-care?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/oue-healthcare-publishes-agm-minutes-and-outlines-strategy-shift-toward-specialised-integrative-care?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","BK4588","AGM","XBI","BK4229","SG","BK4195","BK4585","XLV","BK4209","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637397278","title":"Bamboos Health Care Announces Resignation of Executive Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2637397278","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637397278?lang=en_us&edition=fundamental","pubTime":"2026-05-22 17:14","pubTimestamp":1779441294,"startTime":"0","endTime":"0","summary":"Bamboos Health Care Holdings Ltd ( ($HK:2293) ) just unveiled an update. Bamboos Health Care Holdings Ltd has announced that executive director Mr....","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bamboos-health-care-announces-resignation-of-executive-director?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bamboos-health-care-announces-resignation-of-executive-director?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","BK4588","BK4585","XLV","XBI","LABU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":24,"pageCount":22,"totalSize":465,"code":"91000000","status":"200"}]}}